Vor Biopharma Inc. Basic Shares Outstanding (Weighted Average)
Vor Biopharma Inc. (VOR) reported Basic Shares Outstanding (Weighted Average) of 54.30 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- Vor Biopharma Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 54.30M shares, a 766.99% increase year-over-year.
- Vor Biopharma Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 43.01M shares, a 589.15% increase year-over-year.
- Vor Biopharma Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 20.30M shares, a 479.68% increase year-over-year.
- Vor Biopharma Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 6.68M shares, a 95.17% increase year-over-year.
- Vor Biopharma Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 9.87M shares, a 187.35% increase from fiscal 2024.
- Vor Biopharma Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 3.44M shares, a 94.89% decline from fiscal 2023.
- Vor Biopharma Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 67.19M shares, a 69.89% increase from fiscal 2022.
- Vor Biopharma Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 39.55M shares, a 18.30% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 54.30M shares 10-Q · filed 2026-08-11 | 48.69M shares 10-Q · filed 2026-08-11 | 39.20M shares derived: average of 3 quarters · filed 2026-08-11 | 31.07M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | 43.01M shares 10-Q · filed 2026-05-13 | 31.65M shares derived: average of 2 quarters · filed 2026-05-13 | 23.33M shares derived: average of 3 quarters · filed 2026-05-13 | 19.06M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | 20.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 13.49M shares derived: average of 2 quarters · filed 2026-03-30 | 11.08M shares derived: average of 3 quarters · filed 2026-08-11 | 9.87M shares 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | 6.68M shares 10-Q · filed 2025-11-13 | 6.47M shares derived: average of 2 quarters · filed 2026-08-11 | 6.40M shares 10-Q · filed 2025-11-13 | 5.67M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | 6.26M shares 10-Q · filed 2026-08-11 | 125.27M shares 10-Q · filed 2025-08-12 | 6.25M shares 10-Q · filed 2026-08-11 | 125.05M shares 10-Q · filed 2025-08-12 | 5.34M shares derived: average of 3 quarters · filed 2026-08-11 | 4.86M shares derived: average of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | 6.24M shares 10-Q · filed 2026-05-13 | 124.82M shares 10-Q · filed 2025-05-14 | 4.87M shares derived: average of 2 quarters · filed 2026-05-13 | 4.39M shares derived: average of 3 quarters · filed 2026-05-13 | 20.37M shares derived: average of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | 3.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 3.46M shares derived: average of 2 quarters · filed 2026-03-30 | 25.07M shares derived: average of 3 quarters · filed 2026-03-30 | 3.44M shares 10-K · filed 2026-03-30 | 68.71M shares 10-K · filed 2025-03-20 | |||
| 2024-09-30 | 3.42M shares 10-Q · filed 2025-11-13 | 68.47M shares 10-Q · filed 2024-11-07 | 35.86M shares derived: average of 2 quarters · filed 2025-11-13 | 3.41M shares 10-Q · filed 2025-11-13 | 68.27M shares 10-Q · filed 2024-11-07 | 51.90M shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 68.30M shares 10-Q · filed 2025-08-12 | 68.17M shares 10-Q · filed 2025-08-12 | 68.06M shares derived: average of 3 quarters · filed 2025-08-12 | 67.95M shares derived: average of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | 68.03M shares 10-Q · filed 2025-05-14 | 67.94M shares derived: average of 2 quarters · filed 2025-05-14 | 67.83M shares derived: average of 3 quarters · filed 2025-05-14 | 67.63M shares derived: average of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | 67.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 67.73M shares derived: average of 2 quarters · filed 2025-03-20 | 67.50M shares derived: average of 3 quarters · filed 2025-03-20 | 67.19M shares 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | 67.61M shares 10-Q · filed 2024-11-07 | 67.32M shares derived: average of 2 quarters · filed 2024-11-07 | 66.97M shares 10-Q · filed 2024-11-07 | 61.59M shares derived: average of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | 67.03M shares 10-Q · filed 2024-08-08 | 66.65M shares 10-Q · filed 2024-08-08 | 59.59M shares derived: average of 3 quarters · filed 2024-08-08 | 54.19M shares derived: average of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | 66.27M shares 10-Q · filed 2024-05-09 | 55.86M shares derived: average of 2 quarters · filed 2024-05-09 | 49.91M shares derived: average of 3 quarters · filed 2024-05-09 | 46.79M shares derived: average of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 45.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | 41.73M shares derived: average of 2 quarters · filed 2024-03-20 | 40.30M shares derived: average of 3 quarters · filed 2024-03-20 | 39.55M shares 10-K · filed 2024-03-20 | ||||
| 2022-09-30 | 38.01M shares 10-Q · filed 2023-11-07 | 37.72M shares derived: average of 2 quarters · filed 2023-11-07 | 37.58M shares 10-Q · filed 2023-11-07 | 37.57M shares derived: average of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | 37.44M shares 10-Q · filed 2023-08-10 | 37.37M shares 10-Q · filed 2023-08-10 | 37.42M shares derived: average of 3 quarters · filed 2023-08-10 | 37.30M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 37.29M shares 10-Q · filed 2023-05-11 | 37.41M shares derived: average of 2 quarters · filed 2023-05-11 | 37.25M shares derived: average of 3 quarters · filed 2023-05-11 | 37.15M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 37.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 37.23M shares derived: average of 2 quarters · filed 2023-03-23 | 37.10M shares derived: average of 3 quarters · filed 2023-03-23 | 33.43M shares 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | 36.93M shares 10-Q · filed 2022-11-10 | 36.89M shares derived: average of 2 quarters · filed 2022-11-10 | 32.07M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 36.84M shares 10-Q · filed 2022-08-11 | 29.59M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |